View in EDS

Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer.

Saved in:
Bibliographic Details
Title: Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer.
Authors: Gilbert, Lucy1 (AUTHOR) lucy.gilbert@mcgill.ca, Oaknin, Ana2 (AUTHOR) aoaknin@vhio.net, Matulonis, Ursula A.3 (AUTHOR) Ursula_Matulonis@dfci.harvard.edu, Mantia-Smaldone, Gina M.4 (AUTHOR) gina.mantia-smaldone@fccc.edu, Lim, Peter C.5 (AUTHOR) pclim@cohreno.com, Castro, Cesar M.6 (AUTHOR) cmcastro@mgh.harvard.edu, Provencher, Diane7 (AUTHOR) diane.provencher.chum@ssss.gouv.qc.ca, Memarzadeh, Sanaz8 (AUTHOR) smemarzadeh@mednet.ucla.edu, Method, Michael9 (AUTHOR) michael.method@immunogen.com, Wang, Jiuzhou9 (AUTHOR) joe.wang@immunogen.com, Moore, Kathleen N.10,11 (AUTHOR) kathleen-moore@ouhsc.edu, O'Malley, David M.1,12 (AUTHOR) David.O'Malley@osumc.edu
Source: Gynecologic Oncology. Mar2023, Vol. 170, p241-247. 7p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 162326637
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Gilbert%2C+Lucy%22">Gilbert, Lucy</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> lucy.gilbert@mcgill.ca</i><br /><searchLink fieldCode="AR" term="%22Oaknin%2C+Ana%22">Oaknin, Ana</searchLink><relatesTo>2</relatesTo> (AUTHOR)<i> aoaknin@vhio.net</i><br /><searchLink fieldCode="AR" term="%22Matulonis%2C+Ursula+A%2E%22">Matulonis, Ursula A.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<i> Ursula_Matulonis@dfci.harvard.edu</i><br /><searchLink fieldCode="AR" term="%22Mantia-Smaldone%2C+Gina+M%2E%22">Mantia-Smaldone, Gina M.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<i> gina.mantia-smaldone@fccc.edu</i><br /><searchLink fieldCode="AR" term="%22Lim%2C+Peter+C%2E%22">Lim, Peter C.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<i> pclim@cohreno.com</i><br /><searchLink fieldCode="AR" term="%22Castro%2C+Cesar+M%2E%22">Castro, Cesar M.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<i> cmcastro@mgh.harvard.edu</i><br /><searchLink fieldCode="AR" term="%22Provencher%2C+Diane%22">Provencher, Diane</searchLink><relatesTo>7</relatesTo> (AUTHOR)<i> diane.provencher.chum@ssss.gouv.qc.ca</i><br /><searchLink fieldCode="AR" term="%22Memarzadeh%2C+Sanaz%22">Memarzadeh, Sanaz</searchLink><relatesTo>8</relatesTo> (AUTHOR)<i> smemarzadeh@mednet.ucla.edu</i><br /><searchLink fieldCode="AR" term="%22Method%2C+Michael%22">Method, Michael</searchLink><relatesTo>9</relatesTo> (AUTHOR)<i> michael.method@immunogen.com</i><br /><searchLink fieldCode="AR" term="%22Wang%2C+Jiuzhou%22">Wang, Jiuzhou</searchLink><relatesTo>9</relatesTo> (AUTHOR)<i> joe.wang@immunogen.com</i><br /><searchLink fieldCode="AR" term="%22Moore%2C+Kathleen+N%2E%22">Moore, Kathleen N.</searchLink><relatesTo>10,11</relatesTo> (AUTHOR)<i> kathleen-moore@ouhsc.edu</i><br /><searchLink fieldCode="AR" term="%22O'Malley%2C+David+M%2E%22">O'Malley, David M.</searchLink><relatesTo>1,12</relatesTo> (AUTHOR)<i> David.O'Malley@osumc.edu</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Gynecologic+Oncology%22">Gynecologic Oncology</searchLink>. Mar2023, Vol. 170, p241-247. 7p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=162326637
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ygyno.2023.01.020
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 7
        StartPage: 241
    Titles:
      – TitleFull: Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gilbert, Lucy
      – PersonEntity:
          Name:
            NameFull: Oaknin, Ana
      – PersonEntity:
          Name:
            NameFull: Matulonis, Ursula A.
      – PersonEntity:
          Name:
            NameFull: Mantia-Smaldone, Gina M.
      – PersonEntity:
          Name:
            NameFull: Lim, Peter C.
      – PersonEntity:
          Name:
            NameFull: Castro, Cesar M.
      – PersonEntity:
          Name:
            NameFull: Provencher, Diane
      – PersonEntity:
          Name:
            NameFull: Memarzadeh, Sanaz
      – PersonEntity:
          Name:
            NameFull: Method, Michael
      – PersonEntity:
          Name:
            NameFull: Wang, Jiuzhou
      – PersonEntity:
          Name:
            NameFull: Moore, Kathleen N.
      – PersonEntity:
          Name:
            NameFull: O'Malley, David M.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: Mar2023
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 00908258
          Numbering:
            – Type: volume
              Value: 170
          Titles:
            – TitleFull: Gynecologic Oncology
              Type: main
ResultId 1